Skip to the page

Data / Drug companies / Antidiarrheal

Antidiarrheal drugs: 3 drugs from 25 companies in the FDA NDC directory

Antidiarrheal is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 31 products in this class from 25 companies, covering 3 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on January 1, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

  • 25Companies
  • 31Products
  • 3Drugs by generic name

Drugs in the Antidiarrheal class

Ranked by number of companies that list the drug.

DrugProducts hereCompanies listing it
Diphenoxylate hydrochloride and atropine sulfate2822
Difenoxin and atropine sulfate22
Crofelemer11

Companies with the most products in this class

CompanyProductsMain dosage formsMain marketing categoryNewest product started
A-S Medication Solutions3tabletGeneric drugs (ANDA)March 15, 2020
Aphena Pharma Solutions - Tennessee, LLC2tabletGeneric drugs (ANDA)October 30, 2020
Aphena Pharma Solutions - Tennessee, LLC2tabletAuthorized generics (NDA)June 20, 2017
Bryant Ranch Prepack2tabletGeneric drugs (ANDA)March 15, 2020
Redpharm Drug2tabletGeneric drugs (ANDA)March 15, 2020
American Health Packaging1tabletGeneric drugs (ANDA)August 1, 2025
Ani Pharmaceuticals, Inc.1tabletGeneric drugs (ANDA)July 7, 2017
Chartwell RX, LLC1tabletGeneric drugs (ANDA)October 21, 2020
Direct_Rx1tabletGeneric drugs (ANDA)March 7, 2022
Hikma Pharmaceuticals USA Inc.1solutionGeneric drugs (ANDA)May 3, 1982
Leading Pharma, LLC1tabletGeneric drugs (ANDA)March 15, 2020
Legacy Pharma USA Inc.1tabletNew drug applications (NDA)January 1, 2026
Mylan Pharmaceuticals Inc.1tabletAuthorized generics (NDA)August 7, 2012
Napo Pharmaceuticals, Inc.1tablet, coatedNew drug applications (NDA)August 1, 2016
NuCare Pharmaceuticals,Inc.1tabletGeneric drugs (ANDA)June 20, 2017
PD-Rx Pharmaceuticals, Inc.1tabletGeneric drugs (ANDA)March 15, 2020
Pfizer Laboratories Div Pfizer Inc1tabletNew drug applications (NDA)September 15, 1960
Preferred Pharmaceuticals Inc.1tabletGeneric drugs (ANDA)October 6, 2021
Proficient Rx LP1tabletGeneric drugs (ANDA)March 15, 2020
Proficient Rx LP1tabletGeneric drugs (ANDA)July 7, 2017
Remedyrepack Inc.1tabletGeneric drugs (ANDA)November 16, 2023
Sebela Pharmaceuticals Inc.1tabletNew drug applications (NDA)April 11, 2017
SpecGx LLC1tabletGeneric drugs (ANDA)October 30, 2020
Unichem Pharmaceuticals (USA), Inc.1tabletGeneric drugs (ANDA)May 15, 2019
Winder Laboratories LLC1tabletGeneric drugs (ANDA)April 30, 2022

Dosage forms

Dosage formProductsShare
Tablet2993.5%
Solution13.2%
Tablet, coated13.2%

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.